Evolocumab单抗

Evolocumab

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1256937-27-5

中文名称

Evolocumab单抗

英文名称

Evolocumab

别名

Evolocumab;AMG 145;Research Grade Evolocumab(DHJ24002);AMG-145,Ser/Thr Protease,Repatha,AMG 145,inhibit,atherosclerotic cardiovascular disease,Serine endopeptidases,PCSK9,Evolocumab,AMG145,Threonine proteases,hypercholesterolemia,LDLR,Inhibitor,Serine proteases;Evolocumab(anti-PCSK9);Research Grade Evolocumab;Evolocumab - solution - 5 mg/ml

标准英文名

2-((cyclopropylmethyl)imino)-3-(1-(4-fluorophenyl)ethyl)-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)imidazolidin-4-one--2-(butylimino)-3-(1-(4-fluorophenyl)ethyl)-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)imidazolidin-4-one--2-(ethylimino)-3-(1-(4-fluorophenyl)ethyl)-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)imidazolidin-4-one--3-(1-(4-fluorophenyl)ethyl)-2-((3-hydroxypropyl)imino)-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)imidazolidin-4-one--3-(1-(4-fluorophenyl)ethyl)-2-methoxy-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)-3,5-dihydro-4H-imidazol-4-one (1/1/1/1/1)

分子式

C129H135F5N24O12

分子量

2308.65

精确分子量

2307.06

SMILES

CCCCN=C1NC(=CC2=CC(OC)=C(N3C=NC(C)=C3)C=C2)C(=O)N1C(C)C1=CC=C(F)C=C1.CCN=C1NC(=CC2=CC(OC)=C(N3C=NC(C)=C3)C=C2)C(=O)N1C(C)C1=CC=C(F)C=C1.COC1=C(N2C=NC(C)=C2)C=CC(C=C2NC(=NCC3CC3)N(C(C)C3=CC=C(F)C=C3)C2=O)=C1.COC1=C(N2C=NC(C)=C2)C=CC(C=C2NC(=NCCCO)N(C(C)C3=CC=C(F)C=C3)C2=O)=C1.COC1=NC(=CC2=CC(OC)=C(N3C=NC(C)=C3)C=C2)C(=O)N1C(C)C1=CC=C(F)C=C1

标准SMILES

CCCCN=C1NC(=CC2=CC(OC)=C(C=C2)N2C=C(C)N=C2)C(=O)N1C(C)C1=CC=C(F)C=C1.CCN=C1NC(=CC2=CC(OC)=C(C=C2)N2C=C(C)N=C2)C(=O)N1C(C)C1=CC=C(F)C=C1.CC1=CN(C=N1)C1C=CC(=CC=1OC)C=C1NC(=NCCCO)N(C(C)C2=CC=C(F)C=C2)C1=O.CC1=CN(C=N1)C1C=CC(=CC=1OC)C=C1NC(=NCC2CC2)N(C(C)C2=CC=C(F)C=C2)C1=O.CC1=CN(C=N1)C1C=CC(=CC=1OC)C=C1N=C(OC)N(C(C)C2=CC=C(F)C=C2)C1=O

用途

Evolocumab is indicated for the treatment of homozygous familial hypercholesterolemia in adults and adolescents aged 12 years and older, and for the treatment of adults with atherosclerotic cardiovascular disease to reduce the risk of myocardial infarction, stroke, and coronary revascularization.

InChIKey

PUHBRGRYFZDQIV-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  1256937-27-5 逆合成路线 1

—
—
ACNZKV794
870837-18-6
ACVTJQ814
1256937-27-5
来源: SureRoute

2.  1256937-27-5 逆合成路线 2

ACQXZG980
456-16-6
—
—
ACVTJQ814
1256937-27-5
来源: SureRoute

3.  1256937-27-5 逆合成路线 3

ACWQSL870
65130-46-3
—
—
ACVTJQ814
1256937-27-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手